fentanyl has been researched along with guanosine 5'-o-(3-thiotriphosphate) in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 8 (47.06) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nahorski, SR; Traynor, JR | 1 |
| Fitzgerald, LW; Teitler, M | 1 |
| Akil, H; Lee, KO; Traynor, JR; Woods, JH | 1 |
| Acosta-Burruel, M; Espitia, SA; Hawkinson, JE | 1 |
| Akil, H; Bonner, G; Meng, F | 1 |
| Assié, MB; Bardin, L; Carilla-Durand, E; Colpaert, FC; Cosi, C; Koek, W; Pauwels, PJ; Tarayre, JP; Vacher, B; Wiesenfeld-Hallin, Z; Xu, XJ | 1 |
| Hall, SF; Loh, HH; Mizoguchi, H; Nagase, H; Narita, M; Sora, I; Tseng, LF; Uhl, GR; Wu, HE | 1 |
| Diaz, MF; Gutstein, HB; Moulédous, L | 1 |
| Callado, LF; Dardonville, C; Fernandez-Fernandez, C; Gabilondo, AM; Gibbons, SL; Jagerovic, N; Meana, JJ; Ryan, GJ | 1 |
| Dahan, A; Danhof, M; Kan, J; Olofsen, E; Suidgeest, E; Yassen, A | 1 |
| Binder, W; Brack, A; Fischer, O; Mousa, SA; Rittner, HL; Schäfer, M; Shakibaei, M; Shaqura, M; Stein, C; Urban, F; Zöllner, C | 1 |
| Chi, ZQ; Liu, JG; Sun, JF; Tao, YM; Wang, YH; Xu, XJ | 1 |
| Asato, M; Devi, LA; Hojo, M; Imai, S; Kuzumaki, N; Nakamura, A; Narita, M; Ozeki, A; Rahmadi, M; Sudo, Y; Suzuki, T; Uezono, Y | 1 |
| Callado, LF; Erdozain, AM; Fernández-Fernández, C; Fernández-Ruiz, J; Girón, R; Goya, P; Jagerovic, N; López-Moreno, JA; Martín, MI; Meana, JJ; Morales, P; Rodríguez de Fonseca, F; Sánchez, E | 1 |
| Bird, MF; Calò, G; Guerrini, R; Hruby, VJ; Lambert, DG; McDonald, J; Rowbotham, DJ; Salvadori, S; Trapella, C; Vardanyan, RS | 1 |
| Cussac, D; Heusler, P; Tardif, S | 1 |
| Banks, ML; Negus, SS; Schwienteck, KL | 1 |
17 other study(ies) available for fentanyl and guanosine 5'-o-(3-thiotriphosphate)
| Article | Year |
|---|---|
Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.
Topics: Diprenorphine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Fentanyl; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Diphosphate; Humans; Narcotics; Neuroblastoma; Receptors, Opioid, mu; Tumor Cells, Cultured | 1995 |
Quantitative autoradiographic analysis of [3H]carfentanil binding to mu opiate receptors in the rat brain.
Topics: Animals; Autoradiography; Brain; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Fentanyl; Guanosine 5'-O-(3-Thiotriphosphate); Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Tissue Distribution; Tritium | 1993 |
Differential binding properties of oripavines at cloned mu- and delta-opioid receptors.
Topics: Analgesics, Opioid; Animals; Benzamides; Binding, Competitive; Buprenorphine; Cloning, Molecular; Diprenorphine; Dose-Response Relationship, Drug; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Etorphine; Fentanyl; Guanosine 5'-O-(3-Thiotriphosphate); Morphine; Naloxone; Piperazines; Radioligand Assay; Rats; Receptors, Opioid, delta; Receptors, Opioid, mu; Sulfur Radioisotopes; Thebaine; Tritium; Tumor Cells, Cultured | 1999 |
Opioid activity profiles indicate similarities between the nociceptin/orphanin FQ and opioid receptors.
Topics: Animals; Fentanyl; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Male; Narcotics; Nociceptin; Nociceptin Receptor; Opioid Peptides; Rats; Rats, Sprague-Dawley; Receptors, Opioid | 2000 |
Selectivity of mu-opioid receptor determined by interfacial residues near third extracellular loop.
Topics: Amino Acid Substitution; Animals; Benzamides; Benzomorphans; Binding Sites; Binding, Competitive; COS Cells; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Fentanyl; Guanosine 5'-O-(3-Thiotriphosphate); Ligands; Morphine; Mutation; Naloxone; Naltrexone; Narcotic Antagonists; Peptides; Piperazines; Protein Conformation; Radioligand Assay; Rats; Receptors, Opioid, mu; Signal Transduction; Sulfur Radioisotopes | 2000 |
Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia.
Topics: Acetates; Adrenergic Uptake Inhibitors; Amines; Aminopyridines; Analgesia; Analgesics; Animals; Cells, Cultured; CHO Cells; Cricetinae; Cyclohexanecarboxylic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Drug Synergism; Female; Fentanyl; Gabapentin; gamma-Aminobutyric Acid; Guanosine 5'-O-(3-Thiotriphosphate); Hyperalgesia; Imipramine; Ketamine; Male; Morphine; Pain; Pain Measurement; Pain Threshold; Piperidines; Pyridines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Agents; Time Factors; Transfection | 2002 |
Lack of mu-opioid receptor-mediated G-protein activation in the spinal cord of mice lacking Exon 1 or Exons 2 and 3 of the MOR-1 gene.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Exons; Fentanyl; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); In Vitro Techniques; Mice; Mice, Knockout; Morphine Derivatives; Nociceptin; Nociceptin Receptor; Oligopeptides; Opioid Peptides; Radioligand Assay; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Spinal Cord | 2003 |
Modulation of extracellular signal-regulated kinase (ERK) activity by acute and chronic opioid treatment in neuronal and glial cell lines.
Topics: Animals; Blotting, Western; Cell Line, Tumor; Diprenorphine; Drug Administration Schedule; Enzyme Activation; Fentanyl; Glioma; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Ligands; Mitogen-Activated Protein Kinases; Naloxone; Narcotic Antagonists; Narcotics; Neuroblastoma; Neuroglia; Neurons; Radioligand Assay; Rats; Time Factors | 2004 |
Synthesis and pharmacological studies of new hybrid derivatives of fentanyl active at the mu-opioid receptor and I2-imidazoline binding sites.
Topics: Analgesics, Opioid; Animals; Binding Sites; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Fentanyl; Guanidine; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Imidazoline Receptors; In Vitro Techniques; Indicators and Reagents; Male; Membranes; Mice; Naloxone; Narcotic Antagonists; Pain Measurement; Prefrontal Cortex; Reaction Time; Receptors, Drug; Receptors, Opioid, mu; Structure-Activity Relationship | 2006 |
Mechanism-based pharmacokinetic-pharmacodynamic modeling of the respiratory-depressant effect of buprenorphine and fentanyl in rats.
Topics: Animals; Buprenorphine; Fentanyl; Guanosine 5'-O-(3-Thiotriphosphate); Male; Models, Biological; Narcotics; Rats; Rats, Wistar; Respiration | 2006 |
Chronic morphine use does not induce peripheral tolerance in a rat model of inflammatory pain.
Topics: Animals; beta-Endorphin; Cells, Cultured; Cyclophosphamide; Drug Tolerance; Fentanyl; Guanosine 5'-O-(3-Thiotriphosphate); Inflammation; Male; Morphine; Neurons, Afferent; Pain; Rats; Rats, Wistar; Receptors, Opioid, mu | 2008 |
Paradoxical relationship between RAVE (relative activity versus endocytosis) values of several opioid receptor agonists and their liability to cause dependence.
Topics: Analgesics, Opioid; Animals; Cell Membrane; CHO Cells; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; Endocytosis; Etorphine; Fentanyl; Guanosine 5'-O-(3-Thiotriphosphate); Morphine; Opioid-Related Disorders; Receptors, Opioid, mu | 2010 |
Possible involvement of prolonging spinal µ-opioid receptor desensitization in the development of antihyperalgesic tolerance to µ-opioids under a neuropathic pain-like state.
Topics: Analgesics, Opioid; Animals; beta-Endorphin; Dose-Response Relationship, Drug; Drug Tolerance; Female; Fentanyl; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Hot Temperature; Hyperalgesia; Injections, Subcutaneous; Ligation; Male; Mice; Mice, Knockout; Morphine; Neuralgia; Oxycodone; Pain Measurement; Pain Threshold; Radioligand Assay; Receptors, Opioid, mu; Sciatic Nerve; Sodium Chloride; Spinal Cord | 2013 |
Combining rimonabant and fentanyl in a single entity: preparation and pharmacological results.
Topics: Animals; Dose-Response Relationship, Drug; Fentanyl; Guanosine 5'-O-(3-Thiotriphosphate); Male; Mice; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Structure-Activity Relationship | 2014 |
Development and characterisation of novel fentanyl-delta opioid receptor antagonist based bivalent ligands.
Topics: Animals; Arrestins; beta-Arrestins; CHO Cells; Cricetinae; Cricetulus; Dipeptides; Drug Discovery; Fentanyl; Guanosine 5'-O-(3-Thiotriphosphate); Ligands; Receptors, Opioid, delta; Receptors, Opioid, mu; Tetrahydroisoquinolines | 2015 |
Agonist stimulation at human μ opioid receptors in a [(35)S]GTPγS incorporation assay: observation of "bell-shaped" concentration-response relationships under conditions of strong receptor G protein coupling.
Topics: Animals; Cricetinae; Cricetulus; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Fentanyl; Gene Expression Regulation; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Diphosphate; Humans; Morphine; Naloxone; Receptors, Opioid, mu; Sodium | 2016 |
Sex differences in the effectiveness of buprenorphine to decrease rates of responding in rhesus monkeys.
Topics: Analgesics; Animals; Behavior, Animal; Buprenorphine; Conditioning, Operant; Dose-Response Relationship, Drug; Female; Fentanyl; Guanosine 5'-O-(3-Thiotriphosphate); Ligands; Macaca mulatta; Male; Naltrexone; Receptors, Opioid, mu; Sex Factors | 2019 |